Publication | Closed Access
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
141
Citations
34
References
2024
Year
GliomaImmunotherapyMedicineImmunologyPembrolizumab ShowImmune Checkpoint InhibitorAnti-cancer AgentHigh-grade GliomasCancer TreatmentRadiation OncologyOncologyCell TransplantationPhase 1Peripheral Infusions
| Year | Citations | |
|---|---|---|
Page 1
Page 1